Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.87
0.148.09%
At close: -
$1.90
0.031.60%
After Hours: 7:57 PM EDT
Comments
Loading...
Humacyte Analyst Ratings and Price Targets | NASDAQ:HUMA | Benzinga
Humacyte Inc has a consensus price target of $12.3 based on the ratings of 10 analysts. The high is $25 issued by D. Boral Capital on May 13, 2025. The low is $3 issued by Piper Sandler on November 10, 2023. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Benchmark, and D. Boral Capital on May 14, 2025, May 14, 2025, and May 13, 2025, respectively. With an average price target of $14.33 between HC Wainwright & Co., Benchmark, and D. Boral Capital, there's an implied 654.39% upside for Humacyte Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Benchmark
D. Boral Capital
HC Wainwright & Co.
EF Hutton
1calculated from analyst ratings
Analyst Ratings for Humacyte
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/14/2025 | Buy Now | 110.53% | HC Wainwright & Co. | Swayampakula Ramakanth52% | → $4 | Assumes | → Buy | Get Alert |
| 05/14/2025 | Buy Now | 636.84% | Benchmark | Bruce Jackson39% | $17 → $14 | Maintains | Buy | Get Alert |
| 05/13/2025 | Buy Now | 1215.79% | D. Boral Capital | Jason Kolbert43% | $25 → $25 | Maintains | Buy | Get Alert |
| 03/31/2025 | Buy Now | 1215.79% | D. Boral Capital | Jason Kolbert43% | $25 → $25 | Maintains | Buy | Get Alert |
| 03/28/2025 | Buy Now | 1215.79% | D. Boral Capital | Jason Kolbert43% | $25 → $25 | Maintains | Buy | Get Alert |
| 03/26/2025 | Buy Now | 1215.79% | D. Boral Capital | Jason Kolbert43% | $25 → $25 | Maintains | Buy | Get Alert |
| 03/12/2025 | Buy Now | 689.47% | HC Wainwright & Co. | Vernon Bernardino48% | $15 → $15 | Reiterates | Buy → Buy | Get Alert |
| 03/07/2025 | Buy Now | 1215.79% | D. Boral Capital | Jason Kolbert43% | $25 → $25 | Maintains | Buy | Get Alert |
| 02/27/2025 | Buy Now | — | Benchmark | Bruce Jackson39% | — | Reiterates | Buy → Buy | Get Alert |
| 02/27/2025 | Buy Now | 1215.79% | D. Boral Capital | Jason Kolbert43% | $25 → $25 | Maintains | Buy | Get Alert |
| 02/26/2025 | Buy Now | 1215.79% | D. Boral Capital | Jason Kolbert43% | $25 → $25 | Maintains | Buy | Get Alert |
| 01/21/2025 | Buy Now | 1215.79% | D. Boral Capital | Jason Kolbert43% | $25 → $25 | Maintains | Buy | Get Alert |
| 01/13/2025 | Buy Now | 1215.79% | D. Boral Capital | Jason Kolbert43% | $25 → $25 | Maintains | Buy | Get Alert |
| 12/23/2024 | Buy Now | 794.74% | Benchmark | Bruce Jackson39% | $15 → $17 | Maintains | Buy | Get Alert |
| 12/20/2024 | Buy Now | 1215.79% | D. Boral Capital | Jason Kolbert43% | $25 → $25 | Maintains | Buy | Get Alert |
| 12/20/2024 | Buy Now | 689.47% | HC Wainwright & Co. | Vernon Bernardino48% | $12 → $15 | Reiterates | Buy → Buy | Get Alert |
| 11/21/2024 | Buy Now | 1215.79% | D. Boral Capital | Jason Kolbert43% | $25 → $25 | Maintains | Buy | Get Alert |
| 11/18/2024 | Buy Now | 531.58% | HC Wainwright & Co. | Vernon Bernardino48% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
| 11/13/2024 | Buy Now | 531.58% | HC Wainwright & Co. | Vernon Bernardino48% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
| 11/11/2024 | Buy Now | 1215.79% | D. Boral Capital | Jason Kolbert43% | $25 → $25 | Maintains | Buy | Get Alert |
| 11/05/2024 | Buy Now | 531.58% | HC Wainwright & Co. | Vernon Bernardino48% | $6 → $12 | Maintains | Buy | Get Alert |
| 10/28/2024 | Buy Now | 1215.79% | EF Hutton | Jason Kolbert43% | $25 → $25 | Maintains | Buy | Get Alert |
| 10/18/2024 | Buy Now | 426.32% | TD Cowen | Joshua Jennings55% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 10/18/2024 | Buy Now | 426.32% | BTIG | Ryan Zimmerman71% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 10/10/2024 | Buy Now | 689.47% | Benchmark | Bruce Jackson39% | $15 → $15 | Reiterates | Buy → Buy | Get Alert |
| 10/01/2024 | Buy Now | 1215.79% | EF Hutton | Jason Kolbert43% | $25 → $25 | Maintains | Buy | Get Alert |
| 09/20/2024 | Buy Now | 584.21% | Cantor Fitzgerald | Kristen Kluska67% | $13 → $13 | Reiterates | Overweight → Overweight | Get Alert |
| 09/09/2024 | Buy Now | 1215.79% | EF Hutton | Jason Kolbert43% | → $25 | Initiates | → Buy | Get Alert |
| 09/05/2024 | Buy Now | 689.47% | Benchmark | Bruce Jackson39% | $15 → $15 | Reiterates | Buy → Buy | Get Alert |
| 08/14/2024 | Buy Now | 689.47% | Benchmark | Bruce Jackson39% | $15 → $15 | Reiterates | Buy → Buy | Get Alert |
| 08/12/2024 | Buy Now | 689.47% | Benchmark | Bruce Jackson39% | $15 → $15 | Reiterates | Buy → Buy | Get Alert |
| 07/15/2024 | Buy Now | 478.95% | BTIG | Ryan Zimmerman71% | $8 → $11 | Maintains | Buy | Get Alert |
| 07/02/2024 | Buy Now | 268.42% | Cantor Fitzgerald | Kristen Kluska67% | $7 → $7 | Reiterates | Overweight → Overweight | Get Alert |
| 07/02/2024 | Buy Now | 689.47% | Benchmark | Bruce Jackson39% | $15 → $15 | Reiterates | Buy → Buy | Get Alert |
| 05/24/2024 | Buy Now | 689.47% | Benchmark | Bruce Jackson39% | $15 → $15 | Reiterates | Buy → Buy | Get Alert |
| 05/13/2024 | Buy Now | 689.47% | Benchmark | Bruce Jackson39% | $15 → $15 | Reiterates | Buy → Buy | Get Alert |
| 04/01/2024 | Buy Now | 268.42% | Cantor Fitzgerald | Kristen Kluska67% | $7 → $7 | Reiterates | Overweight → Overweight | Get Alert |
| 03/26/2024 | Buy Now | 110.53% | Piper Sandler | Allison Bratzel63% | $4 → $4 | Maintains | Neutral | Get Alert |
| 03/25/2024 | Buy Now | 689.47% | Benchmark | Bruce Jackson39% | $15 → $15 | Reiterates | Buy → Buy | Get Alert |
| 03/08/2024 | Buy Now | 110.53% | Piper Sandler | Allison Bratzel63% | $3 → $4 | Maintains | Neutral | Get Alert |
| 12/27/2023 | Buy Now | 689.47% | Benchmark | Bruce Jackson39% | $16 → $15 | Maintains | Buy | Get Alert |
| 12/11/2023 | Buy Now | 215.79% | HC Wainwright & Co. | Vernon Bernardino48% | → $6 | Initiates | → Buy | Get Alert |
| 11/10/2023 | Buy Now | 57.89% | Piper Sandler | Matt O'Brien52% | $3.5 → $3 | Maintains | Neutral | Get Alert |
| 09/21/2023 | Buy Now | 268.42% | Cantor Fitzgerald | Kristen Kluska67% | → $7 | Reiterates | Overweight → Overweight | Get Alert |
| 08/31/2023 | Buy Now | 215.79% | Cantor Fitzgerald | Kristen Kluska67% | → $6 | Reiterates | Overweight → Overweight | Get Alert |
| 08/24/2023 | Buy Now | 215.79% | Cantor Fitzgerald | Kristen Kluska67% | → $6 | Reiterates | Overweight → Overweight | Get Alert |
| 08/15/2023 | Buy Now | 742.11% | Benchmark | Bruce Jackson39% | → $16 | Reiterates | Buy → Buy | Get Alert |
| 06/22/2023 | Buy Now | 215.79% | Cantor Fitzgerald | Kristen Kluska67% | → $6 | Initiates | → Overweight | Get Alert |
| 06/12/2023 | Buy Now | 742.11% | Benchmark | Bruce Jackson39% | → $16 | Reiterates | Buy → Buy | Get Alert |
| 03/27/2023 | Buy Now | 742.11% | Benchmark | Bruce Jackson39% | → $16 | Reiterates | → Buy | Get Alert |
| 07/18/2022 | Buy Now | 426.32% | BTIG | Ryan Zimmerman71% | $12 → $10 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Humacyte (HUMA) stock?
The latest price target for Humacyte (NASDAQ:HUMA) was reported by HC Wainwright & Co. on May 14, 2025. The analyst firm set a price target for $4.00 expecting HUMA to rise to within 12 months (a possible 110.53% upside). 35 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Humacyte (HUMA)?
The latest analyst rating for Humacyte (NASDAQ:HUMA) was provided by HC Wainwright & Co., and Humacyte their buy rating.
When was the last upgrade for Humacyte (HUMA)?
There is no last upgrade for Humacyte
When was the last downgrade for Humacyte (HUMA)?
There is no last downgrade for Humacyte.
When is the next analyst rating going to be posted or updated for Humacyte (HUMA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Humacyte, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Humacyte was filed on May 14, 2025 so you should expect the next rating to be made available sometime around May 14, 2026.
Is the Analyst Rating Humacyte (HUMA) correct?
While ratings are subjective and will change, the latest Humacyte (HUMA) rating was a with a price target of $0.00 to $4.00. The current price Humacyte (HUMA) is trading at is $1.90, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
